The market was up slightly in August with the ASX All Ordinaries Accumulation Index up 0.4%, however the story was mixed between sectors. Energy was the worst performing sector with the ASX 300 Energy Accumulation Index down 6.2% for the month, while Financials was the best performer with the ASX 300 Financial Accumulation Index up 7.2% largely driven by the banks. The ASX 300 Health Care Accumulation Index was down 0.9% with the largest stock in the index, CSL, falling 0.8%.
For the Pharma & Biotech coverage universe, there were some significant gainers with 11 stocks in the universe increasing by more than 30% in August and 57 of the 149 stocks delivering a positive share price performance. In this edition of Movers & Shakers for Pharma & Biotech we take a look at 5 companies whose share prices rallied in August.